// App-Quantinova.ai

1497 : Vincristine Sulfate Liposomes Injection (VSLI, Marqibo): Interim Results From a Phase I Study in Children and Adolescents with Refractory Cancer

Researchers

Presenter

  • Melinda Merchant

Principal Investigators

  • Diane Cole

  • Kelly Richards

  • Cindy Delbrook

  • Brigitte C Widemann

  • Alan S Wayne

Medical Centers

  • Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Solid malignancies

  • Neutropenia

  • Peripheral neuropathy

  • Lymphomas

Biomarkers

  • Aspartate aminotransferase

  • Breakpoint Cluster Region

Drug/Treatment

  • Vincristine

Outcome

  • N/A

Study Design

  • pharmacokinetics

  • pharmacodynamics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved